Biogen, Inc. (BIIB)
176.02
-4.52
(-2.50%)
USD |
NASDAQ |
Apr 16, 16:00
175.99
-0.03
(-0.02%)
After-Hours: 20:00
Biogen Cash from Investing (Quarterly) : -1.232B for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen, Inc. | -693.00M |
| Gilead Sciences, Inc. | -1.835B |
| Johnson & Johnson | -- |
| Apellis Pharmaceuticals, Inc. | -0.108M |
| Moderna, Inc. | -48.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 511.90M |
| Cash from Financing (Quarterly) | -137.00M |
| Free Cash Flow | 1.969B |
| Free Cash Flow Per Share (Quarterly) | 2.738 |
| Free Cash Flow to Equity (Quarterly) | 334.20M |
| Free Cash Flow to Firm (Quarterly) | 460.64M |
| Free Cash Flow Yield | 7.62% |